Global EditionASIA 中文雙語Fran?ais
    Business
    Home / Business / Companies

    Investors make a beeline for WuXi AppTec shares

    By Cai Xiao | China Daily | Updated: 2018-05-26 11:51
    Share
    Share - WeChat
    Interior view of the headquarters of WuXi Biologics' parent firm, WuXi AppTec, in Shanghai, April 23, 2018. [Photo/IC]

    Leading contract research outsourcing provider WuXi AppTec saw its A-share price jump by the daily limit of 10 percent again on Friday after 13 consecutive trading days of gains to 107.36 yuan ($16.80).

    The market capitalization of the newly listed company totaled 111.9 billion yuan on Friday, ranked fifth by market capitalization among A-share listed pharmaceutical and biotechnology companies.

    Jiangsu Hengrui Medicine Co Ltd, Kangmei Pharmaceutical Co Ltd, Yunnan Baiyao Group Co Ltd and Shanghai Fosun Pharmaceutical Group Co Ltd were the other four firms.

    WuXi AppTec became the most profitable new share as investors could earn about 86,000 yuan for every 1,000 shares based on Friday's stock performance.

    The trading volume of WuXi AppTec totaled 272 million yuan on Friday, compared with 57.6 million yuan on Thursday.

    WuXi AppTec released a statement on Friday afternoon to remind investors of paying attention to the company's operating risks after 14 consecutive trading days of gains.

    "The nation levied no tariffs on imported anti-cancer drugs, as well as imported potency drugs, which also forced domestic drug manufacturers to upgrade their products, creating great opportunities for contract research organizations, with WuXi AppTec taking a lead.

    "Besides, as the market is opening up, there are limited enterprises that are able to offer qualified products, this explains why the company is favored by investors," said Chen Qiaoshan, senior medical analyst at Beijing-based internet consultancy Analysys.

    WuXi AppTech, formerly known as WuXi PharmaTech (Cayman) Inc, was listed at the New York Stock Exchange in 2007 and went private in 2015. WuXi PharmaTech (Cayman) Inc was divided into three companies then: Pharmaceutical Co Ltd listed at China's new third board in 2015, Wuxin Biologics went public in Hong Kong in 2017 and WuXi AppTech, which was listed in May.

    Zheng Yiran contributed to this story.

    Top
    BACK TO THE TOP
    English
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
    CLOSE
     
    无码精品第一页| 中文字幕乱码无码人妻系列蜜桃 | 中文字幕AV中文字无码亚| 最新无码A∨在线观看| 天堂中文在线最新版| av潮喷大喷水系列无码| 成人无码AV一区二区| 中文字幕在线免费观看| 国色天香中文字幕在线视频| 少妇人妻无码精品视频| 久久久无码精品亚洲日韩蜜臀浪潮| 中文有无人妻vs无码人妻激烈| 91久久九九无码成人网站| 无码精品久久久久久人妻中字| 内射人妻少妇无码一本一道| 日韩中文字幕在线视频| 天堂在线资源中文在线8| 97免费人妻无码视频| 午夜不卡久久精品无码免费| 人妻AV中出无码内射| 中文字幕乱码人妻综合二区三区| 日本中文字幕电影| 久久精品aⅴ无码中文字字幕不卡| 免费无码午夜福利片69| a级毛片无码兔费真人久久| 久久久久无码精品国产不卡| 亚洲国产精品无码久久SM| 成人午夜精品无码区久久| 无码成人精品区在线观看| 亚洲中文字幕伊人久久无码| 久久亚洲中文字幕精品一区| 最近更新中文字幕在线| 中文字幕在线最新在线不卡| 最近中文字幕大全免费视频| 久久中文精品无码中文字幕| 最好看的电影2019中文字幕| 国产av无码专区亚洲av果冻传媒 | 特级做A爰片毛片免费看无码| 欧美日韩中文字幕在线看| 亚洲国产午夜中文字幕精品黄网站 | 亚洲AV无码一区二区二三区软件 |